0001493152-24-005370.txt : 20240208 0001493152-24-005370.hdr.sgml : 20240208 20240208073009 ACCESSION NUMBER: 0001493152-24-005370 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240207 FILED AS OF DATE: 20240208 DATE AS OF CHANGE: 20240208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOLL ANDREW R. CENTRAL INDEX KEY: 0001542150 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 24606862 MAIL ADDRESS: STREET 1: 437 S HWY 101 STREET 2: STE 209 CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER NAME: FORMER CONFORMED NAME: Boll Andrew DATE OF NAME CHANGE: 20120210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: HARROW HEALTH, INC. DATE OF NAME CHANGE: 20181228 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 4 1 ownership.xml X0508 4 2024-02-07 0 0001360214 HARROW, INC. HROW 0001542150 BOLL ANDREW R. C/O HARROW, INC. 102 WOODMONT BLVD, SUITE 610 NASHVILLE TN 37205 0 1 0 0 CHIEF FINANCIAL OFFICER 0 Common stock 2024-02-07 4 M 0 7400 7.71 A 541569 D Stock Option (Right to Buy) 7.71 2024-02-07 4 M 0 7400 0 D 2024-02-10 Common Stock 7400 0 D Represents stock options granted to Mr. Boll on February 10, 2014 under the Issuer's 2007 Stock Incentive and Awards Plan, as amended. The stock option vested quarterly over a three-year period following the grant date. The total exercise price for the options ($57,054) was paid in cash to the Issuer by Mr. Boll. /s/ Andrew R. Boll 2024-02-08